These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10326544)

  • 41. Therapeutic monitoring of mycophenolic acid. A consensus panel report.
    Shaw LM; Nicholls A; Hale M; Armstrong VW; Oellerich M; Yatscoff R; Morris RE; Holt DW; Venkataramanan R; Haley J; Halloran P; Ettenger R; Keown P; Morris RG
    Clin Biochem; 1998 Jul; 31(5):317-22. PubMed ID: 9721428
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of plasmapheresis on mycophenolic acid concentrations.
    Maldonado AQ; Davies NM; Crow SA; Little C; Ojogho ON; Weeks DL
    Transplantation; 2011 Jan; 91(1):e3-4. PubMed ID: 21343877
    [No Abstract]   [Full Text] [Related]  

  • 43. Mycophenolate mofetil in dermatomyositis: is it safe?
    Rowin J; Amato AA; Deisher N; Cursio J; Meriggioli MN
    Neurology; 2006 Apr; 66(8):1245-7. PubMed ID: 16636243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of mycophenolate mofetil for steroid and cyclosporine resistant membranoproliferative glomerulonephritis type I.
    Ito S; Tsutsumi A; Inaba A; Machida H; Harada T; Yokota S
    Pediatr Nephrol; 2009 Aug; 24(8):1593-4. PubMed ID: 19224249
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful therapy for bullous pemphigoid with mycophenolate mofetil.
    Nousari HC; Griffin WA; Anhalt GJ
    J Am Acad Dermatol; 1998 Sep; 39(3):497-8. PubMed ID: 9738791
    [No Abstract]   [Full Text] [Related]  

  • 46. Improvement of liver function in a paediatric patient with biliary cirrhosis after triple immunosuppression with Mycophenolate following renal transplantation.
    Ermisch B; Kirste G; Brandis M; Zimmerhackl LB
    Nephrol Dial Transplant; 1998 May; 13(5):1325. PubMed ID: 9623586
    [No Abstract]   [Full Text] [Related]  

  • 47. Mycophenolate mofetil: a decade of clinical experience.
    Danovitch GM
    Transplantation; 2005 Oct; 80(2 Suppl):S272-4. PubMed ID: 16251860
    [No Abstract]   [Full Text] [Related]  

  • 48. Expanding the immunosuppressive repertoire.
    Ascher NL
    Liver Transpl Surg; 1996 Jul; 2(4):304-5. PubMed ID: 9346666
    [No Abstract]   [Full Text] [Related]  

  • 49. Response to letter from van Gelder. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients.
    Hübner GI; Sziegoleit W
    Ther Drug Monit; 2000 Aug; 22(4):498-9. PubMed ID: 10942194
    [No Abstract]   [Full Text] [Related]  

  • 50. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.
    Nousari HC; Goyal S; Anhalt GJ
    Arch Dermatol; 1999 Nov; 135(11):1420-1. PubMed ID: 10566854
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunosuppression with mycophenolic acid: one size does not fit all.
    Bennett WM
    J Am Soc Nephrol; 2003 Sep; 14(9):2414-6. PubMed ID: 12937322
    [No Abstract]   [Full Text] [Related]  

  • 52. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.
    Köse O; Safali M; Bulent Tastan H; Gur AR
    Dermatology; 2004; 209(1):69-70. PubMed ID: 15237274
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of retroperitoneal fibrosis by mycophenolate mofetil and corticosteroids.
    Grotz W; von Zedtwitz I; Andre M; Schollmeyer P
    Lancet; 1998 Oct; 352(9135):1195. PubMed ID: 9777843
    [No Abstract]   [Full Text] [Related]  

  • 54. Quantification of mycophenolic acid in plasma samples collected during and immediately after intravenous administration of mycophenolate mofetil.
    Shipkova M; Armstrong VW; Kiehl MG; Niedmann PD; Schütz E; Oellerich M; Wieland E
    Clin Chem; 2001 Aug; 47(8):1485-8. PubMed ID: 11468247
    [No Abstract]   [Full Text] [Related]  

  • 55. Impact of sirolimus on renal transplant outcomes in African Americans.
    Podder H; Podbielski J; Hussein I; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2001; 33(1-2):1226. PubMed ID: 11267269
    [No Abstract]   [Full Text] [Related]  

  • 56. Bacillary angiomatosis in a renal transplant recipient.
    Cline MS; Cummings OW; Goldman M; Filo RS; Pescovitz MD
    Transplantation; 1999 Jan; 67(2):296-8. PubMed ID: 10075597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mycophenolate mofetil: a report of the consensus panel.
    Shaw LM; Sollinger HW; Halloran P; Morris RE; Yatscoff RW; Ransom J; Tsina I; Keown P; Holt DW; Lieberman R
    Ther Drug Monit; 1995 Dec; 17(6):690-9. PubMed ID: 8588243
    [No Abstract]   [Full Text] [Related]  

  • 58. Is there hope to improve chronic renal allograft outcome?
    Goral S; Helderman JH
    Transplantation; 2000 Jun; 69(11):2239-40. PubMed ID: 10868619
    [No Abstract]   [Full Text] [Related]  

  • 59. Drugs that interact with immunosuppressive agents.
    Trotter JF
    Semin Gastrointest Dis; 1998 Jul; 9(3):147-53. PubMed ID: 9700845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rationale for trials of long-term mycophenolate mofetil therapy for primary biliary cirrhosis.
    Jones EA
    Hepatology; 2002 Feb; 35(2):258-62. PubMed ID: 11826397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.